For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20240924:nRSX4919Fa&default-theme=true
RNS Number : 4919F Dr. Martens PLC 24 September 2024
Dr. Martens plc (the 'Company')
Director/PDMR Shareholding
Notification of Transactions by Directors/Persons Discharging Managerial
Responsibility
The Company announces that it was notified on 24 September 2024 of the
following transaction in the Company's Ordinary 1p shares (the 'shares')
undertaken by a director / person discharging managerial responsibility
('PDMRs'):
* In order to effect a 'Bed and ISA' transaction, Robyn Perriss, Independent
Non-Executive Director, sold 89,054 ordinary shares of 1 pence each in the
Company ('Ordinary Shares') at a price of £0.515 per Ordinary Share and then
repurchased 89,054 Ordinary Shares into her ISA at a price of £0.5155 per
Ordinary Share. Following these transactions, Robyn's overall beneficial
interest in the Company's Ordinary Shares remains unchanged at 99,328 Ordinary
Shares.
The relevant notifications, set out below, are provided in accordance with the
requirements of Article 19 of the UK Market Abuse Regulation.
1 Details of the person discharging managerial responsibilities/person closely
associated
a) Name Robyn Perriss
2 Reason for the notification
a) Position/status PDMR (Non-Executive Director)
b) Initial notification/Amendment Initial notification
3 Details of the issuer, emission allowance market participant, auction
platform, auctioneer or auction monitor
a) Name Dr. Martens plc
b) LEI 213800QPT8YM6NQZPH28
4 Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted
a) Description of the financial instrument, type of instrument Ordinary shares of GBP 0.01
Identification code ISIN: GB00BL6NGV24
b) Nature of the transaction Sale of Ordinary Shares in order to effect a
Bed & Isa transaction
c) Price(s) and volume(s) Price(s) Volume(s)
£0.515 89,054
d) Aggregated information
- Aggregated volume
- Price Single transaction
e) Date of the transaction 24 September 2024
f) Place of the transaction London Stock Exchange (XLON)
d)
Aggregated information
- Aggregated volume
- Price
Single transaction
e)
Date of the transaction
24 September 2024
f)
Place of the transaction
London Stock Exchange (XLON)
1 Details of the person discharging managerial responsibilities/person closely
associated
a) Name Robyn Perriss
2 Reason for the notification
a) Position/status PDMR (Non-Executive Director)
b) Initial notification/Amendment Initial notification
3 Details of the issuer, emission allowance market participant, auction
platform, auctioneer or auction monitor
a) Name Dr. Martens plc
b) LEI 213800QPT8YM6NQZPH28
4 Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted
a) Description of the financial instrument, type of instrument Ordinary shares of GBP 0.01
Identification code ISIN: GB00BL6NGV24
b) Nature of the transaction Purchase of Ordinary Shares to complete a
Bed & Isa transaction
c) Price(s) and volume(s) Price(s) Volume(s)
£0.5155 89,054
d) Aggregated information
- Aggregated volume
- Price Single transaction
e) Date of the transaction 24 September 2024
f) Place of the transaction London Stock Exchange (XLON)
d)
Aggregated information
- Aggregated volume
- Price
Single transaction
e)
Date of the transaction
24 September 2024
f)
Place of the transaction
London Stock Exchange (XLON)
For further information please contact:
Paul Rolling
Assistant Company Secretary
paul.rolling@drmartens.com
+4475 8424 3562
Bethany Barnes
Director of Investor Relations
bethany.barnes@drmartens.com
+4478 2518 7465
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END DSHUSVVRSRUKUAR